News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
683,756 Results
Type
Article (66437)
Company Profile (128)
Press Release (617191)
Section
Business (188080)
Career Advice (2767)
Deals (34506)
Drug Delivery (88)
Drug Development (80100)
Employer Resources (154)
FDA (16231)
Job Trends (14913)
News (328386)
Policy (32368)
Tag
Academia (2935)
Alliances (46815)
Alzheimer's disease (1205)
Approvals (16144)
Artificial intelligence (121)
Bankruptcy (318)
Best Places to Work (11291)
Biotechnology (88)
Breast cancer (107)
Cancer (905)
Cardiovascular disease (80)
Career advice (2342)
Cell therapy (207)
Clinical research (63253)
Collaboration (322)
Compensation (115)
COVID-19 (2621)
C-suite (80)
Data (851)
Diabetes (132)
Diagnostics (6151)
Drug pricing (83)
Earnings (65808)
Employer resources (137)
Events (100392)
Executive appointments (249)
FDA (16681)
Funding (284)
Gene therapy (151)
GLP-1 (586)
Government (4663)
Healthcare (19211)
Infectious disease (2690)
Inflammatory bowel disease (105)
Interviews (525)
IPO (15495)
Job creations (3899)
Job search strategy (1984)
Layoffs (449)
Legal (7409)
Lung cancer (156)
Manufacturing (142)
Medical device (14055)
Medtech (14060)
Mergers & acquisitions (19044)
Metabolic disorders (359)
Neuroscience (1439)
NextGen Class of 2024 (6781)
Non-profit (4575)
Northern California (1112)
Obesity (212)
Opinion (211)
Patents (95)
People (59963)
Phase I (19585)
Phase II (27755)
Phase III (20675)
Pipeline (201)
Postmarket research (2718)
Preclinical (8378)
Radiopharmaceuticals (245)
Rare diseases (181)
Real estate (6315)
Regulatory (21525)
Research institute (2492)
Resumes & cover letters (411)
Southern California (1003)
Startups (3674)
United States (10928)
Vaccines (557)
Weight loss (168)
Date
Today (88)
Last 7 days (712)
Last 30 days (2681)
Last 365 days (34344)
2024 (29051)
2023 (38503)
2022 (49558)
2021 (54486)
2020 (53668)
2019 (47640)
2018 (36223)
2017 (32903)
2016 (32657)
2015 (38236)
2014 (31326)
2013 (27829)
2012 (29373)
2011 (29490)
2010 (28165)
Location
Africa (919)
Arizona (158)
Asia (40860)
Australia (7229)
California (2467)
Canada (1118)
China (204)
Colorado (117)
Connecticut (114)
Europe (92748)
Florida (375)
Georgia (98)
Illinois (341)
Indiana (167)
Kansas (93)
Maryland (516)
Massachusetts (1931)
Michigan (145)
Minnesota (250)
New Jersey (785)
New York (762)
North Carolina (698)
Northern California (1112)
Ohio (123)
Pennsylvania (698)
South America (1253)
Southern California (1003)
Texas (368)
Washington State (295)
683,756 Results for "medical university of vienna".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its scientific collaborators, Drs. Vern Lewis and Argel Aguilar-Valles from Carleton University’s Department of Neuroscience (Ottawa, Canada), will present data from a study investigating the mechanisms of BETR-001 (2-bromo-LSD) at the upcoming FENS conference on June 25-29 in Vienna, Austria.
June 26, 2024
·
4 min read
News
Spineway generates great interest at the EUROSPINE 2024 Congress in Vienna
October 22, 2024
·
2 min read
Press Releases
Boehringer Ingelheim expands cancer research at its Vienna site
September 26, 2024
·
3 min read
Business
MOBILion Partners with BOKU Vienna to Introduce High-Resolution Ion Mobility in Europe
MOBILion Systems, Inc., a life science tools and instrumentation company, has partnered with The University of Natural Resources and Life Sciences, Vienna, an Agilent Partner Lab, to install its first MOBIE® instrument in Europe.
January 4, 2024
·
2 min read
Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria
Median Technologies announces that the Company will be participating and speaking at the premier European radiology conference, the European Congress of Radiology, being held in Vienna, Austria, February 28 – March 3, 2024.
February 26, 2024
·
3 min read
Biotech Beach
iTrack™ Advance Real-World Registry Data and CATALYST Study Data to be Presented at the 2023 ESCRS Annual Congress, Vienna
Nova Eye Medical Limited is pleased to announce that the Company’s proprietary canaloplasty technology platform will be featured in numerous presentations and posters during the official scientific program of the European Society of Cataract and Refractive Surgeons 41st Congress on September 8-12, 2023 in Vienna, Austria.
September 6, 2023
·
8 min read
Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study
AMRA Medical in collaboration with Linköping University, is pleased to announce the completion of baseline enrollment for the innovative ACCESS-ESLD study.
April 25, 2024
·
5 min read
Press Releases
KSQ Therapeutics Appoints Anna Truppel-Hartmann, M.D., as Chief Medical Officer
October 8, 2024
·
3 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Business
QT Imaging Holdings’ Technology Advances Medical Imaging Research at the University of Oklahoma’s Health Stephenson Cancer Center
QT Imaging Holdings, Inc. is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment.
June 24, 2024
·
5 min read
1 of 68,376
Next